{
  "study_id": "NCT00545077",
  "study_title": "Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study",
  "table_name": "Table 1",
  "table_title": "Clinical Characteristics",
  "footnotes": [
    "*Interval between first diagnosis and first recurrence (ie, study entry)."
  ],
  "groups": [
    {
      "name": "ET",
      "n": 184,
      "type": "Endocrine therapy"
    },
    {
      "name": "ET-B",
      "n": 190,
      "type": "Endocrine therapy plus bevacizumab"
    }
  ],
  "characteristics": [
    {
      "original_label": "Age, years",
      "standardized_name": "Age",
      "unit": "years",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "ET-B",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Age",
      "unit": "years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "numeric_single",
          "value": 66.0,
          "raw_string": "66"
        },
        {
          "group_name": "ET-B",
          "data_type": "numeric_single",
          "value": 64.0,
          "raw_string": "64"
        }
      ]
    },
    {
      "original_label": "Range",
      "standardized_name": "Age Range",
      "unit": "years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "text",
          "text_value": "39-86",
          "raw_string": "39-86"
        },
        {
          "group_name": "ET-B",
          "data_type": "text",
          "text_value": "38-85",
          "raw_string": "38-85"
        }
      ]
    },
    {
      "original_label": "< 40",
      "standardized_name": "Age",
      "category": "< 40 years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.5,
          "raw_string": "1 0.5"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.1,
          "raw_string": "2 1.1"
        }
      ]
    },
    {
      "original_label": "40-64",
      "standardized_name": "Age",
      "category": "40-64 years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 83.0,
          "percentage": 45.2,
          "raw_string": "83 45.2"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 99.0,
          "percentage": 52.1,
          "raw_string": "99 52.1"
        }
      ]
    },
    {
      "original_label": "65-69",
      "standardized_name": "Age",
      "category": "65-69 years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 35.0,
          "percentage": 19.0,
          "raw_string": "35 19.0"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 34.0,
          "percentage": 17.9,
          "raw_string": "34 17.9"
        }
      ]
    },
    {
      "original_label": "70-80",
      "standardized_name": "Age",
      "category": "70-80 years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 58.0,
          "percentage": 31.5,
          "raw_string": "58 31.5"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 47.0,
          "percentage": 24.7,
          "raw_string": "47 24.7"
        }
      ]
    },
    {
      "original_label": "> 80",
      "standardized_name": "Age",
      "category": "> 80 years",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age, years",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 3.8,
          "raw_string": "7 3.8"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 8.0,
          "percentage": 4.2,
          "raw_string": "8 4.2"
        }
      ]
    },
    {
      "original_label": "Country",
      "standardized_name": "Country",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "ET-B",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Spain",
      "standardized_name": "Country",
      "category": "Spain",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Country",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 131.0,
          "percentage": 71.2,
          "raw_string": "131 71.2"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 135.0,
          "percentage": 71.1,
          "raw_string": "135 71.1"
        }
      ]
    },
    {
      "original_label": "Germany",
      "standardized_name": "Country",
      "category": "Germany",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Country",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 53.0,
          "percentage": 28.8,
          "raw_string": "53 28.8"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 55.0,
          "percentage": 28.9,
          "raw_string": "55 28.9"
        }
      ]
    },
    {
      "original_label": "ECOG PS",
      "standardized_name": "ECOG Performance Status",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "ET-B",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "ECOG Performance Status",
      "category": "0",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG PS",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 131.0,
          "percentage": 71.2,
          "raw_string": "131 71.2"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 139.0,
          "percentage": 73.2,
          "raw_string": "139 73.2"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "ECOG Performance Status",
      "category": "1",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG PS",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 53.0,
          "percentage": 28.8,
          "raw_string": "53 28.8"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 51.0,
          "percentage": 26.8,
          "raw_string": "51 26.8"
        }
      ]
    },
    {
      "original_label": "Median disease-free interval, years*",
      "standardized_name": "Disease-Free Interval",
      "unit": "years",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "numeric_single",
          "value": 4.3,
          "raw_string": "4.3"
        },
        {
          "group_name": "ET-B",
          "data_type": "numeric_single",
          "value": 4.3,
          "raw_string": "4.3"
        }
      ]
    },
    {
      "original_label": "Previous (neo)adjuvant chemotherapy",
      "standardized_name": "Previous (neo)adjuvant chemotherapy",
      "category": "Yes",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 88.0,
          "percentage": 47.8,
          "raw_string": "88 47.8"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 83.0,
          "percentage": 43.7,
          "raw_string": "83 43.7"
        }
      ]
    },
    {
      "original_label": "Taxanes, anthracyclines, or both",
      "standardized_name": "Previous (neo)adjuvant chemotherapy type",
      "category": "Taxanes, anthracyclines, or both",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant chemotherapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 66.0,
          "percentage": 35.9,
          "raw_string": "66 35.9"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 65.0,
          "percentage": 34.2,
          "raw_string": "65 34.2"
        }
      ]
    },
    {
      "original_label": "CMF",
      "standardized_name": "Previous (neo)adjuvant chemotherapy type",
      "category": "CMF",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant chemotherapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 21.0,
          "percentage": 11.4,
          "raw_string": "21 11.4"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 18.0,
          "percentage": 9.5,
          "raw_string": "18 9.5"
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "Previous (neo)adjuvant chemotherapy type",
      "category": "Other",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant chemotherapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.5,
          "raw_string": "1 0.5"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "percentage": 0.0,
          "raw_string": "0 0.0"
        }
      ]
    },
    {
      "original_label": "Previous (neo)adjuvant endocrine therapy",
      "standardized_name": "Previous (neo)adjuvant endocrine therapy",
      "category": "Yes",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 95.0,
          "percentage": 51.6,
          "raw_string": "95 51.6"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 100.0,
          "percentage": 52.6,
          "raw_string": "100 52.6"
        }
      ]
    },
    {
      "original_label": "Antiestrogens",
      "standardized_name": "Previous (neo)adjuvant endocrine therapy type",
      "category": "Antiestrogens",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant endocrine therapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 58.0,
          "percentage": 31.5,
          "raw_string": "58 31.5"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 64.0,
          "percentage": 33.7,
          "raw_string": "64 33.7"
        }
      ]
    },
    {
      "original_label": "Aromatase inhibitor",
      "standardized_name": "Previous (neo)adjuvant endocrine therapy type",
      "category": "Aromatase inhibitor",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant endocrine therapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 13.0,
          "percentage": 7.1,
          "raw_string": "13 7.1"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 8.0,
          "percentage": 4.2,
          "raw_string": "8 4.2"
        }
      ]
    },
    {
      "original_label": "Both",
      "standardized_name": "Previous (neo)adjuvant endocrine therapy type",
      "category": "Both",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Previous (neo)adjuvant endocrine therapy",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 24.0,
          "percentage": 13.0,
          "raw_string": "24 13.0"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 28.0,
          "percentage": 14.7,
          "raw_string": "28 14.7"
        }
      ]
    },
    {
      "original_label": "Stage of disease at study entry",
      "standardized_name": "Stage of disease at study entry",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "ET-B",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Locally advanced",
      "standardized_name": "Stage of disease at study entry",
      "category": "Locally advanced",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Stage of disease at study entry",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 6.0,
          "percentage": 3.3,
          "raw_string": "6 3.3"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 5.0,
          "percentage": 2.6,
          "raw_string": "5 2.6"
        }
      ]
    },
    {
      "original_label": "Metastatic",
      "standardized_name": "Stage of disease at study entry",
      "category": "Metastatic",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Stage of disease at study entry",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 178.0,
          "percentage": 96.7,
          "raw_string": "178 96.7"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 185.0,
          "percentage": 97.4,
          "raw_string": "185 97.4"
        }
      ]
    },
    {
      "original_label": "No. of metastatic sites",
      "standardized_name": "Number of metastatic sites",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "ET-B",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Single",
      "standardized_name": "Number of metastatic sites",
      "category": "Single",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "No. of metastatic sites",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 67.0,
          "percentage": 36.4,
          "raw_string": "67 36.4"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 80.0,
          "percentage": 42.1,
          "raw_string": "80 42.1"
        }
      ]
    },
    {
      "original_label": "Multiple",
      "standardized_name": "Number of metastatic sites",
      "category": "Multiple",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "No. of metastatic sites",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 117.0,
          "percentage": 63.6,
          "raw_string": "117 63.6"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 110.0,
          "percentage": 57.9,
          "raw_string": "110 57.9"
        }
      ]
    },
    {
      "original_label": "Visceral disease",
      "standardized_name": "Visceral disease",
      "category": "Yes",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 88.0,
          "percentage": 47.8,
          "raw_string": "88 47.8"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 47.4,
          "raw_string": "90 47.4"
        }
      ]
    },
    {
      "original_label": "Lung",
      "standardized_name": "Visceral disease site",
      "category": "Lung",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Visceral disease",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 69.0,
          "percentage": 37.5,
          "raw_string": "69 37.5"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 62.0,
          "percentage": 32.6,
          "raw_string": "62 32.6"
        }
      ]
    },
    {
      "original_label": "Liver",
      "standardized_name": "Visceral disease site",
      "category": "Liver",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Visceral disease",
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 19.6,
          "raw_string": "36 19.6"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 20.5,
          "raw_string": "39 20.5"
        }
      ]
    },
    {
      "original_label": "Bone disease",
      "standardized_name": "Bone disease",
      "category": "Yes",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 118.0,
          "percentage": 64.1,
          "raw_string": "118 64.1"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 124.0,
          "percentage": 65.3,
          "raw_string": "124 65.3"
        }
      ]
    },
    {
      "original_label": "Measurable disease",
      "standardized_name": "Measurable disease",
      "category": "Yes",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "ET",
          "data_type": "categorical_count_percentage",
          "count": 146.0,
          "percentage": 79.3,
          "raw_string": "146 79.3"
        },
        {
          "group_name": "ET-B",
          "data_type": "categorical_count_percentage",
          "count": 142.0,
          "percentage": 74.7,
          "raw_string": "142 74.7"
        }
      ]
    }
  ]
}